Benralizumab 61434-0066-00
- Manufacturer
- Catalent Indiana, Llc
- Dosage Form
- Injection, Solution
- Product Type
- Human Prescription Drug
- Marketing Start
- June 3, 2024
- Listing Expires
- December 31, 2026
Need to source Benralizumab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Benralizumab | 10 mg/.5mL |
Selected Package
61434-0066-00Selected1280 SYRINGE in 1 CASE (61434-066-00) / .5 mL in 1 SYRINGE